Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:00
’It’s a special game’: Waukesha West High School spreads...
-
2:23
DOJ investigating Minnesota governor, Minneapolis mayor over...
-
2:07
Local businesses carry anti-ICE signs and whistles as tensions...
-
1:03
Sen. Baldwin demands answers regarding Trump admin’s mental...
-
2:03
Faith leaders call for neighbors to record, intervene if ICE...
-
1:58
Milwaukee woman sentenced in crash that killed 1-year-old, family...
-
2:05
Lifelong Packers fans score dream gender reveal party thanks...
-
2:54
Visit Milwaukee preview: Jan. 16-18
-
2:16
41st annual Waukesha Janboree kicks off with ’Out of This World’...
-
3:58
Winter Weather Advisory issued, snow continues overnight
-
1:10
Trade in your winter coat for a pontoon boat -- Milwaukee Boat...
-
2:22
Meet CBS 58’s Pet of the Week: Snoopy
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.